74 results
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
our existing and acquired net operating losses and other tax attributes to offset taxable income. In addition, we raised capital in October 2019, June … 2020 and March 2022, which may further limit our ability to utilize our net operating losses and other tax attributes to offset taxable income
424B5
myqgp8t
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
h0g0t9lpbrjgt3lsjxhc
9 Nov 22
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:11pm
424B5
7kfwuk v3a5n
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
pbs5neo8yx7 68h57pi
28 Mar 22
Prospectus supplement for primary offering
4:53pm